Skip to main content
Clinical Trials/NCT03166332
NCT03166332
Completed
Not Applicable

Improving Mothers for a Better PrenAtal Care Trial Barcelona

Hospital Clinic of Barcelona2 sites in 1 country1,221 target enrollmentFebruary 1, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Intrauterine Growth Restriction
Sponsor
Hospital Clinic of Barcelona
Enrollment
1221
Locations
2
Primary Endpoint
Fetal Growth Restriction (FGR)
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

High risk women for growth restricted fetuses will randomized in the second trimester into different strategies applied to the mothers: a stress reduction program based on mindfulness techniques or a nutrition interventional program based on Mediterranean diet.

Detailed Description

Randomized controlled trial among women at higher risk to have a growth restricted fetus (30%) according to Royal College of Obstetrics and Gynecology (RCOG) Guidelines. These high-risk women will be randomized in order to evaluate an improvement in several outcomes thanks to different strategies applied to the mothers: a stress reduction program based on mindfulness techniques or a nutrition interventional program based on Mediterranean diet. Main hypothesis: specific interventions improving maternal lifestyle and well being have a positive impact on pregnancy outcomes as well as on fetal growth and development. Secondary hypothesis is that interventions to improve maternal lifestyle well being have a positive impact on offspring's outcome later in life, in terms of neurodevelopment and cardiovascular profile, mediated by epigenetic changes in offspring.

Registry
clinicaltrials.gov
Start Date
February 1, 2017
End Date
December 31, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Eduard Gratacós Solsona

Director of ICGON and BCNatal

Hospital Clinic of Barcelona

Eligibility Criteria

Inclusion Criteria

  • Maternal age at recruitment ≥18 years
  • Speak Spanish fluently
  • Viable singleton non-malformed fetus
  • High-risk pregnancy to develop FGR.
  • 19-23 weeks of gestation

Exclusion Criteria

  • Fetal anomalies including chromosomal abnormalities or structural malformations detected by ultrasound.
  • Mental retardation or other mental or psychiatric disorders that impose doubts regarding the true patient´s willingness to participate in the study.
  • No possibility to come to additional visits.

Outcomes

Primary Outcomes

Fetal Growth Restriction (FGR)

Time Frame: Delivery

Birth weight \<10th percentile

Secondary Outcomes

  • Adverse Perinatal Outcome (APO) Adverse Perinatal Outcome (APO)(Pregnancy)

Study Sites (2)

Loading locations...

Similar Trials